Navigation Links
Weight Management is Not Enough for Cannabinoid Type 1 (CB1),Receptor Antagonists to Become a Commercial Success

Huge clinical development program of first-in-class CB1 antagonist rimonabant to show benefits beyond weight reduction and avoid image as life-style drug

BARCELONA, Spain | March 08, 2007 | The Business Intelligence firm La Merie S.L. reported today that Sanofi-Aventis’ first-in-class CB1 antagonist Acomplia (rimonabant) has at least five competitors in clinical stages up to phase III and many more in earlier phases of R&D. While Acomplia received EU approval in June 2006, the FDA requested more time to review the file. Acomplia is indicated for the treatment of patients with obesity or overweight plus cardiometabolic risk factors and achieved EU sales of € 31 mln in its first months in selected markets. However, some countries such as Germany consider Acomplia as a non-reimbursable life-style drug. Sanofi-Aventis is undertaking a huge clinical program to profile Acomplia in additional populations such as in type 2 diabetes (1st line), insulinized patients, dyslipidemia or atherosclerosis. Another field of potential use of CB1 antagonists lies in neuroscience, such as addiction and cognitive disorders. These results and more were found in a search conducted by La Merie Business Intelligence. The competitor analysis of CB1 antagonists can be acquired at www.pipelinereview.com, La Merie’s News Center and Online Store.

Rimonabant has been studied in more than 6,000 patients. Results of the RIO-LIPIDS study showed that a one-year treatment of overweight and obese patients with abnormal lipid levels with once daily rimonabant significantly reduced body weigth by an average of 6.9 kg in comparison to a loss of 1.5 kg in the placebo group. More importantly, it improved a range of cardiometabolic risk factors that may contribute to type 2 diabetes and heart disease. Results of a two-year treatment with rimonabant in the RIO-
'"/>




Page: 1 2 3

Related medicine technology :

1. Elixir Pharmaceuticals Presents Additional Preclinical Data Demonstrating the Potential of Ghrelin Antagonism to Regulate Metabolism, Body Weight and Glycemic Control
2. Breaking Multi-Center Study: Masimo SET Pulse Oximetry Technology Shown to Significantly Lower Instances of Severe Retinopathy of Prematurity in Extremely Low Birth Weight Infants
3. New Data Show Xenical Significantly Reduces Cardiovascular Risk and More Than Doubles Weight Loss Achieved in Overweight and Obese People
4. New Data Confirm That Use of Levemir Can Limit Weight Gain
5. Safety Analyses of Clinical Data for Bifeprunox in Patients with Schizophrenia Showed a Favorable Weight and Lipid Profile, Similar to Placebo
6. Choosing Lab Quality Management Software
7. Optimizing Quality Control Data Management
8. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
9. Geron Corp. Licensee TA Sciences Announces Landmark 7/07/07 Teleconference to Answer Questions About TA-65, Their Telomerase Activator With Proven Age Management Benefits
10. Vakzine Projekt Management Reports Positive Clinical Trial Results With Their Therapeutic Prostate Cancer Vaccine VPM4001
11. Oculus Innovative Sciences Microcyn Technology Presented in Poster at European Wound Management Association Conference
Post Your Comments:
(Date:9/15/2014)... , Sept. 15, 2014 Research and ... Worldwide Market for In Vitro Diagnostic Tests, 9th Edition" ... covers the entirety of the clinical testing market and all ... Used by Top IVD Companies For Business Planning. ... based on the market events of 2013 and early 2014. ...
(Date:9/15/2014)... , Sept. 15, 2014 Biomerics ... the medical device market, announced its merger with ... Advanced Catheter Division. The new division was formed to ... device solutions for the structure heart, interventional radiology, ... Biomerics Advanced Catheter will be led by ...
(Date:9/15/2014)... , Sept. 15, 2014  MedExpress Urgent Care, a ... is now offering flu shots for ages four and up ... advising patients to get their flu shot early. ... at the end of June, making late summer and early ... flu season. MedExpress Vice President of Provider and Clinical Quality, ...
Breaking Medicine Technology:The Worldwide Market for In Vitro Diagnostic Tests, 9th Edition 2The Worldwide Market for In Vitro Diagnostic Tests, 9th Edition 3Biomerics and Access Point Technologies OEM Announce Merger and Creation of Biomerics Advanced Catheter Division 2MedExpress Quotes Late Summer, Early Fall As Best Time to Receive Flu Shot 2
... Since the 1950s, the American,Heart Association (AHA) ... take,antibiotics before having dental work or other procedures ... were supposed to prevent,infective endocarditis, a potentially serious ... the latest evidence, the AHA now emphasizes routine,oral ...
... Board Recommends Continuing Study, NEW YORK, Oct. ... announced today the completion of interim analysis of ... drug candidate,pafuramidine. An independent Data Safety Monitoring Board ... trial should continue as,planned. The trial is evaluating ...
Cached Medicine Technology:For Most, Good Oral Care Does More Than Antibiotics to Prevent Dental-Related Heart Problems, Reports the Harvard Heart Letter 2Immtech Announces Interim Analysis in Phase III African Sleeping Sickness Trial 2Immtech Announces Interim Analysis in Phase III African Sleeping Sickness Trial 3Immtech Announces Interim Analysis in Phase III African Sleeping Sickness Trial 4
(Date:9/15/2014)... The Best Hospitals Honor Roll ... of seven hospitals using OnBase as their enterprise ... Clinic were ranked at the top of the list, ... cover nearly 5,000 medical centers across the country with ... scored highest in at least six of the sixteen ...
(Date:9/15/2014)... Dotinga HealthDay Reporter , ... cholesterol-lowering drugs are more likely to fill their prescriptions ... generic brands, new research suggests. At issue are ... Crestor, Zocor and Lipitor. Generic statins are also available. ... heart problems due to clogged arteries. About ...
(Date:9/15/2014)... The White House has recently begun shifting ... jail and prison and toward helping them access addiction ... positive change. , The nation is currently grappling with ... to an article from The Washington Post , ... away from using the criminal justice system to address ...
(Date:9/15/2014)... Dennis Thompson ... News) -- The severe respiratory virus believed to have ... states has now spread to the Northeast, health officials ... confirmed on Friday more than a dozen cases of ... for children with asthma. And on Saturday, the ...
(Date:9/15/2014)... Array Health , an independent ... that Independence Blue Cross (Independence), the ... selected the Array Spectrum™ Private Exchange solution for ... employers with more than 100 employees. Using the ... offer employer groups a comprehensive selection of products ...
Breaking Medicine News(10 mins):Health News:Seven of Top Ten Hospitals in the U.S. Leverage OnBase by Hyland ECM Solution 2Health News:Older Patients More Likely to Fill Prescriptions for Generic Statins: Study 2Health News:Older Patients More Likely to Fill Prescriptions for Generic Statins: Study 3Health News:White House Shifts Policy on Drugs 2Health News:Kids' Severe Respiratory Virus Confirmed in Northeast 2Health News:Kids' Severe Respiratory Virus Confirmed in Northeast 3Health News:Independence Blue Cross Selects Array Spectrum™ Private Health Insurance Exchange Technology 2Health News:Independence Blue Cross Selects Array Spectrum™ Private Health Insurance Exchange Technology 3
... to press ahead or wait; job creation is public,s top ... of Americans want some kind of health reform in the ... a good thing if the legislation proposed by the Democrats ... if health reform would be good or bad for the ...
... , , FAIRFIELD, N.J. , Feb. 11 ... without the right footwear. And the actual surface for the ... Athletic™ lineup of portable fitness mats and interlocking gym flooring ... basic stretching, Shock Athletic products offer a broad range of ...
... , ... a lawyer with the Louthian Law Firm in Columbia, S.C., says developments in lawsuits ... cannot seek justice. , ... Columbia, South Carolina (PRWEB) February 11, 2010 -- The anti-smoking patch Chantix continues ...
... ... panic as the long-term shortage of Armour Thyroid, Nature-Throid, and Westhroid continues. The ... is a little-known secret that thousands of Americans have already discovered. There is ... ...
... ... Humber NHS Framework, in addition to two in Dec & Jan, with Acute & Mental ... , ... 11, 2010 -- BigHand, a leading provider of voice technology to the healthcare market, has ...
... , DENVER, CO , Feb. 10 ... ( MIT ) is pleased to announce that its ... the production certification to produce Med-Jet products in China ... subject of a recent visit by the SFDA. These facilities ...
Cached Medicine News:Health News:Poll Shows Eroding Support for Health Reform 2Health News:Poll Shows Eroding Support for Health Reform 3Health News:Poll Shows Eroding Support for Health Reform 4Health News:For a Healthier, Cleaner Fitness Regimen - Venture Products' Shock Athletic(TM) Mats and Interlocking Flooring 2Health News:For a Healthier, Cleaner Fitness Regimen - Venture Products' Shock Athletic(TM) Mats and Interlocking Flooring 3Health News:South Carolina Attorney Says Legal Options Still Available To Those Harmed By Chantix 2Health News:South Carolina Attorney Says Legal Options Still Available To Those Harmed By Chantix 3Health News:No End In Sight To The Armour Thyroid Shortage? 2Health News:No End In Sight To The Armour Thyroid Shortage? 3Health News:Three NHS Trusts Choose BigHand Voice Technology Under YHCPC Framework Agreement 2Health News:Major milestone achieved by our joint venture in China 2Health News:Major milestone achieved by our joint venture in China 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: